Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
Q2 2026 vs. Q1 2026
How the institutions holding Sunshine Biopharma Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 12 | 9 | −3 |
| Shares | 122.2K | 15.5K | −106.7K (−87.3%) |
| Value | $127.1K | $32.6K | −$94.5K (−74.3%) |
New holders (3)
Institutions that held Sunshine Biopharma Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 14,974 | $31.4K | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | $2 | 0.00% |
| Strive Financial Group ,LLC | 1 | $2 | 0.00% |
Sold out (6)
Institutions that held Sunshine Biopharma Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Citadel Advisors LLC | 46,248 | $48.1K |
| Two Sigma Securities, LLC | 23,482 | $24.4K |
| XTX Topco Ltd | 21,457 | $22.3K |
| Commonwealth Equity Services, LLC | 13,437 | $14.0K |
| UBS Group AG | 1,103 | $1.15K |
| CoreCap Advisors, LLC | 1 | $1 |